Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
about
Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerMonovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agentBiology of MET: a double life between normal tissue repair and tumor progressionHepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic TargetHepatocyte growth factor/scatter factor-induced intracellular signalling.c-Met modulates RPE migratory response to laser-induced retinal injury.A novel isoform of met receptor tyrosine kinase blocks hepatocyte growth factor/Met signaling and stimulates skeletal muscle cell differentiation.A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells.Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations.Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesisParacrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal MelanomaProto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.Scatter factor induces blood vessel formation in vivo.Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis networkMet/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancersTumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factorImpact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancerOverexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy.Contribution of human hematopoietic stem cells to liver repair.Vascular complications and diabetes: current therapies and future challenges.Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma.Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.Regulation of scatter factor production via a soluble inducing factor.Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy.Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.Are hepatocyte growth factor-like protein and macrophage stimulating protein the same protein?Role of HGF/c-Met in serum-starved ARPE-19 cells.In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
P2860
Q27334957-3207F8BA-252D-4912-915D-3D5FBC46060AQ27679191-26AE9EE7-04E1-476A-9D03-7AA466D966A9Q28085247-4971B69B-E7FF-4C87-9377-5D5F2E5FB079Q33565746-7675860C-39D6-4F37-84B2-44EF2D91547CQ33863966-3AE4DF45-D5E7-49CA-AFB7-28B5D21B2973Q34342411-0090E316-6B13-4C4A-8674-B0F54082F838Q35121348-865BB560-AD29-44AD-8E2E-DE8A32CCF5BBQ35213426-49147E40-9E55-4A2B-BCCF-AB0C13379C5EQ35426283-07C4C545-7C9A-4DFB-817F-12B456548AB9Q35753150-0993E39B-B619-41A6-B69C-F73CF98EED21Q35773856-D2BD3037-219B-4E01-B2D9-EA5C7773A30CQ35782449-BEBCB35E-CC20-4151-AAA2-F48940E4D999Q35798481-34A8903E-483B-4B1F-9E1D-519963017E44Q35812275-E5BAC552-F07D-4A38-8452-267E6367522BQ35832227-0E231C8F-ACD3-4FF4-9BCD-9583B6E4B2C4Q36065558-C61F8228-2E82-4ADF-A059-D12BEBD28093Q36141804-4B21BE27-B08B-4599-842E-05D4B1DAD1ABQ36326357-716C3D35-67BD-4C46-A3B9-18970B4835F3Q36557528-9AF38C86-4437-40EA-B0E2-B1891997442DQ36621835-25F94766-2D5A-4A98-A592-B09B56C827A7Q36705281-BC1AA83F-B570-47FF-86AA-CAF9BB931156Q36935015-A18CD069-1983-4FF0-8E4C-ACDC3FFB2553Q37253582-E15E8D57-71CD-49EA-BCC2-F66E6F033949Q37521994-3799A87B-338A-4E98-9329-5AB614AB7872Q37978317-C95F29D4-912E-4BEB-9A6E-E62BE9D9AB34Q38482545-02ABF05A-A395-442F-9524-7256B6CC1F3CQ39677451-1DB6EE05-E9F0-456B-A9F5-4D6E3EE56436Q39798868-DB271F46-20FA-4AF1-9EEB-5FEA57C9802EQ40560399-E8BE85D6-8907-4AAB-A74C-8D697087D955Q41438276-F077482A-8A03-416A-A0ED-60D03131A2B3Q42014557-FA23C7BC-F711-4D22-87BD-C730D5223FA1Q42775475-F25E3764-CE2B-4673-9604-E1F27D618297Q42842935-F301B143-792F-4753-BE73-9FA3ACF475C1Q43195112-AEB093D4-6971-4A31-BC71-433403436B8AQ47136514-14C76210-6A24-49B3-A074-9E48EF8CAB11Q58796893-13662B3A-434E-4514-B171-1244261EB737
P2860
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
@en
type
label
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
@en
prefLabel
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
@en
P2093
P1476
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism
@en
P2093
Bhargava M
Donovan MA
Goldberg I
Zarnegar R
P577
1992-01-01T00:00:00Z